Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Single-pass membrane protein with coiled-coil domains 1 (SMCO1, also known as C3orf43) is a membrane protein predicted to be localized to the plasma membrane, containing a conserved but uncharacterized coiled-coil domain (DUF4547)[2][4][5]. It is highly expressed in cardiac and skeletal muscle, where it is implicated in maintaining normal myocyte structure and function, and is also upregulated in proliferating hepatocytes during liver regeneration[1][2]. Disruption of Smco1 in animal models results in myopathy, cardiac hypoplasia, and growth defects[1]. The precise molecular function and complete disease associations remain to be fully elucidated, and there are no currently known drugs, biomarkers, or defined safety concerns associated directly with SMCO1[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single-pass membrane protein with coiled-coil domains 1 (SMCO1).